Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
13
Recruiting, any sponsor type, condition "benign prostatic hyperplasia"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed261
13 trials
Showing 1 to 13, recently updated first.
Ankara City Hospital BilkentAcademic, hospital or other
NCT07417449 · 1,000 participants (planned) · Start Apr 1, 2026 · Primary completion Nov 30, 2026
Drug: Dutasteride · For: Prostatic Hyperplasia, Benign
Sites: Ankara, Turkey (Türkiye)
Hamza NajoutAcademic, hospital or other
NCT07460518 · 80 participants (planned) · Start Mar 30, 2026 · Primary completion Oct 30, 2026
Drug: Tranexamic Acid; Placebo (Normal Saline) · For: Benign Prostatic Hyperplasia; Transurethral Resection of the Prostate; Perioperative Bleeding and 1 more
Sites: Rabat, Morocco
Ain Shams UniversityAcademic, hospital or other
NCT07722884 · 90 participants (planned) · Start Jul 1, 2026 · Primary completion Jan 1, 2027
Drug: Tamsulosin 0.4 mg + Tadalafil 2.5 mg; Tamsulosin 0.4 mg + Tadalafil 5 mg and 1 more · For: Safety; Efficacy; Tamsulosin and 4 more
Sites: Cairo, Egypt
- Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic HyperplasiaPivotal-lookingRecruiting
Beni-Suef UniversityAcademic, hospital or other
NCT07654413 · 320 participants (planned) · Start Jun 8, 2026 · Primary completion Nov 2027
Drug: Tamsulosin; Tadalafil and 1 more · For: Acute Urinary Retention; Benign Prostatic Hyperplasia; Benign Prostatic Obstruction
Sites: Banī Suwayf, Egypt
- Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary RetentionPivotal-lookingRecruiting
Beni-Suef UniversityAcademic, hospital or other
NCT07650968 · 378 participants (planned) · Start Jun 8, 2026 · Primary completion May 2027
Drug: Tamsulosin 0.4 mg; Tamsulosin 0.8 mg and 1 more · For: Acute Urinary Retention; Benign Prostatic Hyperplasia
Sites: Banī Suwayf, Egypt
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaPivotal-lookingRecruiting
Beth Israel Deaconess Medical CenterAcademic, hospital or other
NCT06944145 · 242 participants (planned) · Start Dec 3, 2025 · Primary completion Jun 1, 2029
Drug: raloxifene; Finasteride · For: BPH (Benign Prostatic Hyperplasia); Lower Urinary Track Symptoms
Sites: Boston, Massachusetts
Addpharma Inc.Industry
NCT07444385 · 44 participants (planned) · Start Feb 26, 2026 · Primary completion Apr 22, 2026
Drug: AD-116, AD-1161 · For: Benign Prostatic Hyperplasia
Sites: Seoul, South Korea
- A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the ProstatePivotal-lookingRecruiting
The Fourth Affiliated Hospital of Zhejiang University School of MedicineAcademic, hospital or other
NCT07357324 · 136 participants (planned) · Start Dec 1, 2024 · Primary completion Dec 31, 2026
Drug: Tamsulosin Hydrochloride Sustained-Release Capsules; Lingze Tablets · For: Benign Prostatic Hyperplasia; Nocturia Associated With Nocturnal Polyuria
Sites: Yiwu, China
Yifeng JingAcademic, hospital or other
NCT06689514 · 30 participants (planned) · Start Jan 20, 2025 · Primary completion Dec 31, 2026
Drug: alpha receptor antagonist; Low dose Tranilast and 1 more · For: Prostatic Hypertrophy, Benign
Sites: Shanghai, China · 2 sites in all
Universitas DiponegoroAcademic, hospital or other
NCT07065682 · 84 participants (planned) · Start Jul 1, 2023 · Primary completion Dec 1, 2024
Drug: Aloevera + dutasteride; Dutasteride (0.5mg) · For: BPH (Benign Prostatic Hyperplasia)
Sites: Karawang, Indonesia
Ankara Training and Research HospitalAcademic, hospital or other
NCT06865430 · 82 participants (planned) · Start Mar 4, 2025 · Primary completion Sep 4, 2025
Drug: Tamsulosin Hydrochloride · For: Prostate Hyperplasia
Sites: Ankara, Turkey (Türkiye)
Endeavor HealthAcademic, hospital or other
NCT06062875 · 70 participants (planned) · Start Jan 24, 2024 · Primary completion Apr 1, 2028
Drug: Adalimumab · For: Benign Prostatic Hyperplasia (BPH)
Sites: Glenview, Illinois
Turku University HospitalGovernment (non-federal)
NCT06001619 · 100 participants (planned) · Start Dec 1, 2022 · Primary completion Oct 31, 2024
Drug: Prostate hyperplasia medication; LhRH-antagonist · For: Prostatic Hyperplasia; Prostate Cancer
Sites: Turku, Finland · 2 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.